These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
OREGON
|
|
91-1761992
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
224 Airport Parkway, Suite 400
San Jose, California
|
|
95110
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Large accelerated filer
|
¨
|
|
Accelerated filer
|
¨
|
|
Non-accelerated filer
|
¨
|
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
x
|
|
Emerging growth company
|
¨
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
|
||
|
Item 1.
|
Financial Statements.
|
|
|
September 30,
2017 |
|
December 31,
2016 |
||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
26,329
|
|
|
$
|
19,622
|
|
|
Accounts receivable, net
|
5,084
|
|
|
3,118
|
|
||
|
Inventories
|
5,058
|
|
|
2,803
|
|
||
|
Prepaid expenses and other current assets
|
2,191
|
|
|
736
|
|
||
|
Total current assets
|
38,662
|
|
|
26,279
|
|
||
|
Property and equipment, net
|
6,271
|
|
|
3,793
|
|
||
|
Other assets, net
|
1,111
|
|
|
785
|
|
||
|
Acquired intangible assets, net
|
6,414
|
|
|
—
|
|
||
|
Goodwill
|
18,021
|
|
|
—
|
|
||
|
Total assets
|
$
|
70,479
|
|
|
$
|
30,857
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
2,611
|
|
|
$
|
1,734
|
|
|
Accrued liabilities and current portion of long-term liabilities
|
16,199
|
|
|
7,860
|
|
||
|
Current portion of income taxes payable
|
763
|
|
|
140
|
|
||
|
Total current liabilities
|
19,573
|
|
|
9,734
|
|
||
|
Long-term liabilities, net of current portion
|
2,227
|
|
|
194
|
|
||
|
Convertible debt
|
5,761
|
|
|
—
|
|
||
|
Income taxes payable, net of current portion
|
2,223
|
|
|
1,880
|
|
||
|
Total liabilities
|
29,784
|
|
|
11,808
|
|
||
|
Commitments and contingencies (Note 13)
|
|
|
|
|
|
||
|
Shareholders’ equity:
|
|
|
|
||||
|
Preferred stock
|
—
|
|
|
—
|
|
||
|
Common stock
|
416,607
|
|
|
394,296
|
|
||
|
Accumulated other comprehensive income
|
10
|
|
|
10
|
|
||
|
Accumulated deficit
|
(375,922
|
)
|
|
(375,257
|
)
|
||
|
Total shareholders’ equity
|
40,695
|
|
|
19,049
|
|
||
|
Total liabilities and shareholders’ equity
|
$
|
70,479
|
|
|
$
|
30,857
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Revenue, net (1)
|
$
|
18,758
|
|
|
$
|
13,656
|
|
|
$
|
62,189
|
|
|
$
|
37,403
|
|
|
Cost of revenue (2)
|
9,747
|
|
|
7,099
|
|
|
29,585
|
|
|
20,839
|
|
||||
|
Gross profit
|
9,011
|
|
|
6,557
|
|
|
32,604
|
|
|
16,564
|
|
||||
|
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
|
Research and development (3)
|
5,325
|
|
|
4,442
|
|
|
14,732
|
|
|
14,621
|
|
||||
|
Selling, general and administrative (4)
|
6,583
|
|
|
3,072
|
|
|
15,382
|
|
|
10,117
|
|
||||
|
Restructuring
|
1,481
|
|
|
3
|
|
|
1,481
|
|
|
2,608
|
|
||||
|
Total operating expenses
|
13,389
|
|
|
7,517
|
|
|
31,595
|
|
|
27,346
|
|
||||
|
Income (loss) from operations
|
(4,378
|
)
|
|
(960
|
)
|
|
1,009
|
|
|
(10,782
|
)
|
||||
|
Interest expense and other, net (5)
|
(528
|
)
|
|
(99
|
)
|
|
(728
|
)
|
|
(305
|
)
|
||||
|
Income (loss) before income taxes
|
(4,906
|
)
|
|
(1,059
|
)
|
|
281
|
|
|
(11,087
|
)
|
||||
|
Provision (benefit) for income taxes
|
(200
|
)
|
|
183
|
|
|
902
|
|
|
357
|
|
||||
|
Net loss
|
$
|
(4,706
|
)
|
|
$
|
(1,242
|
)
|
|
$
|
(621
|
)
|
|
$
|
(11,444
|
)
|
|
Net loss per share - basic and diluted
|
$
|
(0.14
|
)
|
|
$
|
(0.04
|
)
|
|
$
|
(0.02
|
)
|
|
$
|
(0.41
|
)
|
|
Weighted average shares outstanding - basic and diluted
|
32,552
|
|
|
28,313
|
|
|
30,545
|
|
|
28,139
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
(1) Includes deferred revenue fair value adjustment
|
$
|
25
|
|
|
$
|
—
|
|
|
$
|
25
|
|
|
$
|
—
|
|
|
(2) Includes:
|
|
|
|
|
|
|
|
||||||||
|
Inventory step-up and backlog amortization
|
1,016
|
|
|
—
|
|
|
1,016
|
|
|
—
|
|
||||
|
Amortization of acquired intangible assets
|
199
|
|
|
—
|
|
|
199
|
|
|
—
|
|
||||
|
Stock-based compensation
|
57
|
|
|
49
|
|
|
179
|
|
|
139
|
|
||||
|
Restructuring
|
—
|
|
|
27
|
|
|
—
|
|
|
1,777
|
|
||||
|
(3) Includes stock-based compensation
|
445
|
|
|
401
|
|
|
1,121
|
|
|
1,222
|
|
||||
|
(4) Includes:
|
|
|
|
|
|
|
|
||||||||
|
Acquisition-related costs
|
1,611
|
|
|
—
|
|
|
2,505
|
|
|
—
|
|
||||
|
Stock-based compensation
|
855
|
|
|
334
|
|
|
1,796
|
|
|
495
|
|
||||
|
Amortization of acquired intangible assets
|
67
|
|
|
—
|
|
|
67
|
|
|
—
|
|
||||
|
(5) Includes:
|
|
|
|
|
|
|
|
||||||||
|
Fair value adjustment on convertible debt conversion option
|
122
|
|
|
—
|
|
|
122
|
|
|
—
|
|
||||
|
Discount accretion on convertible debt fair value
|
72
|
|
|
—
|
|
|
72
|
|
|
—
|
|
||||
|
|
Nine Months Ended September 30,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net loss
|
$
|
(621
|
)
|
|
$
|
(11,444
|
)
|
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
|
|
|
||||
|
Stock-based compensation
|
3,096
|
|
|
1,856
|
|
||
|
Depreciation and amortization
|
2,714
|
|
|
2,638
|
|
||
|
Inventory step-up and backlog amortization
|
1,016
|
|
|
—
|
|
||
|
Amortization of acquired intangible assets
|
266
|
|
|
—
|
|
||
|
Reversal of uncertain tax positions
|
(191
|
)
|
|
(170
|
)
|
||
|
Fair value adjustment on convertible debt conversion option
|
122
|
|
|
—
|
|
||
|
Discount accretion on convertible debt fair value
|
72
|
|
|
—
|
|
||
|
Write off of certain assets to restructuring
|
—
|
|
|
1,744
|
|
||
|
Other
|
106
|
|
|
47
|
|
||
|
Changes in operating assets and liabilities, net of acquisition:
|
|
|
|
||||
|
Accounts receivable, net
|
(998
|
)
|
|
2,093
|
|
||
|
Inventories
|
342
|
|
|
(101
|
)
|
||
|
Prepaid expenses and other current and long-term assets, net
|
76
|
|
|
(40
|
)
|
||
|
Accounts payable
|
(926
|
)
|
|
(973
|
)
|
||
|
Accrued current and long-term liabilities
|
4,597
|
|
|
(297
|
)
|
||
|
Income taxes payable
|
1,158
|
|
|
85
|
|
||
|
Net cash provided by (used in) operating activities
|
10,829
|
|
|
(4,562
|
)
|
||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Purchases of property and equipment
|
(2,300
|
)
|
|
(1,783
|
)
|
||
|
Cash received in connection with acquisition of business
|
1,901
|
|
|
—
|
|
||
|
Net cash used in investing activities
|
(399
|
)
|
|
(1,783
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Payments on line of credit related to acquisition
|
(4,046
|
)
|
|
(3,000
|
)
|
||
|
Proceeds from issuance of common stock under employee equity incentive plans
|
2,196
|
|
|
403
|
|
||
|
Payments on convertible debt
|
(953
|
)
|
|
—
|
|
||
|
Payments on asset financings
|
(920
|
)
|
|
(1,069
|
)
|
||
|
Net cash used in financing activities
|
(3,723
|
)
|
|
(3,666
|
)
|
||
|
Net increase (decrease) in cash and cash equivalents
|
6,707
|
|
|
(10,011
|
)
|
||
|
Cash and cash equivalents, beginning of period
|
19,622
|
|
|
26,591
|
|
||
|
Cash and cash equivalents, end of period
|
$
|
26,329
|
|
|
$
|
16,580
|
|
|
|
|
|
|
||||
|
Supplemental disclosure of cash flow information:
|
|
|
|
||||
|
Cash paid during the period for interest
|
$
|
370
|
|
|
$
|
107
|
|
|
Cash paid for income taxes, net of refunds received
|
284
|
|
|
411
|
|
||
|
Non-cash investing and financing activities:
|
|
|
|
||||
|
Value of shares issued in acquisition
|
$
|
16,975
|
|
|
$
|
—
|
|
|
Acquisitions of property and equipment and other
assets under extended payment terms
|
$
|
3,558
|
|
|
$
|
—
|
|
|
Purchase price
|
|
|
$
|
16,975
|
|
|
|
Less net liabilities assumed:
|
|
|
|
|||
|
Assets acquired:
|
|
|
|
|||
|
Cash and cash equivalents
|
1,901
|
|
|
|
||
|
Accounts receivable
|
968
|
|
|
|
||
|
Inventories
|
3,561
|
|
|
|
||
|
Property and equipment
|
964
|
|
|
|
||
|
Other assets
|
1,562
|
|
|
|
||
|
Identifiable intangible assets
|
6,730
|
|
|
|
||
|
Liabilities assumed:
|
|
|
|
|||
|
Accounts payable
|
(1,736
|
)
|
|
|
||
|
Accrued liabilities and other current liabilities
|
(2,832
|
)
|
|
|
||
|
Revolving bank loan
|
(4,046
|
)
|
|
|
||
|
Convertible debt
|
(6,485
|
)
|
|
|
||
|
Other noncurrent liabilities
|
(1,633
|
)
|
|
(1,046
|
)
|
|
|
Goodwill
|
|
|
$
|
18,021
|
|
|
|
•
|
We performed a valuation of the convertible debt. We assigned
$4,762
of the purchase price to convertible debt, consisting of the contractual amount of
$6,068
offset by a debt discount of
$1,306
, and
$1,723
to the embedded conversion feature. No other features of the debt were assigned value at the acquisition date.
|
|
•
|
We performed a valuation of acquired intangible assets. We have preliminarily assigned
$5,050
of the purchase price to acquired developed technology with estimated lives of
5 years
or less,
$1,270
to customer relationships with estimated lives of
3 years
or less, and
$410
to backlog and trademark with estimated lives of
2 years
or less. ViXS had no in-process research and development.
|
|
•
|
We recorded an inventory step-up of
$2,415
to record inventory at fair value. We will recognize this within cost of goods sold as the inventory is sold which we expect to be over a period of approximately 12 months.
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Revenue, net
|
$
|
19,926
|
|
|
$
|
21,770
|
|
|
$
|
72,315
|
|
|
$
|
58,833
|
|
|
Net income (loss)
|
$
|
(4,052
|
)
|
|
$
|
(3,768
|
)
|
|
$
|
258
|
|
|
$
|
(22,873
|
)
|
|
Net income (loss) per share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
(0.12
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
0.01
|
|
|
$
|
(0.72
|
)
|
|
Diluted
|
$
|
(0.12
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
0.01
|
|
|
$
|
(0.72
|
)
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
33,788
|
|
|
32,021
|
|
|
33,429
|
|
|
31,847
|
|
||||
|
Diluted
|
33,788
|
|
|
32,021
|
|
|
35,516
|
|
|
31,847
|
|
||||
|
|
September 30,
2017 |
|
December 31,
2016 |
||||
|
Accounts receivable, gross
|
$
|
5,124
|
|
|
$
|
3,150
|
|
|
Less: allowance for doubtful accounts
|
(40
|
)
|
|
(32
|
)
|
||
|
Accounts receivable, net
|
$
|
5,084
|
|
|
$
|
3,118
|
|
|
|
Nine Months Ended
|
||||||
|
|
September 30,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Balance at beginning of period
|
$
|
32
|
|
|
$
|
60
|
|
|
Additions charged (reductions credited)
|
8
|
|
|
(21
|
)
|
||
|
Balance at end of period
|
$
|
40
|
|
|
$
|
39
|
|
|
|
September 30,
2017 |
|
December 31,
2016 |
||||
|
Finished goods
|
$
|
2,903
|
|
|
$
|
1,707
|
|
|
Work-in-process
|
2,155
|
|
|
1,096
|
|
||
|
Inventories
|
$
|
5,058
|
|
|
$
|
2,803
|
|
|
|
September 30,
2017 |
|
December 31,
2016 |
||||
|
Gross carrying amount
|
$
|
27,898
|
|
|
$
|
24,416
|
|
|
Less: accumulated depreciation and amortization
|
(21,627
|
)
|
|
(20,623
|
)
|
||
|
Property and equipment, net
|
$
|
6,271
|
|
|
$
|
3,793
|
|
|
|
September 30,
2017 |
|
December 31,
2016 |
||||
|
Developed technology
|
$
|
5,050
|
|
|
$
|
—
|
|
|
Customer relationships
|
1,270
|
|
|
—
|
|
||
|
Backlog and tradename
|
410
|
|
|
—
|
|
||
|
|
6,730
|
|
|
—
|
|
||
|
Less: accumulated amortization
|
(316
|
)
|
|
—
|
|
||
|
Acquired intangible assets, net
|
$
|
6,414
|
|
|
$
|
—
|
|
|
Three months ending December 31:
|
|
||
|
2017
|
$
|
610
|
|
|
Years ending December 31:
|
|
||
|
2018
|
1,596
|
|
|
|
2019
|
1,505
|
|
|
|
2020
|
1,496
|
|
|
|
2021
|
1,117
|
|
|
|
2022
|
90
|
|
|
|
|
$
|
6,414
|
|
|
|
September 30,
2017 |
|
December 31,
2016 |
||||
|
Accrued payroll and related liabilities
|
$
|
4,149
|
|
|
$
|
2,169
|
|
|
Accrued commissions and royalties
|
2,618
|
|
|
2,427
|
|
||
|
Accrued interest payable
|
2,492
|
|
|
2,078
|
|
||
|
Current portion of accrued liabilities for asset financings
|
1,822
|
|
|
389
|
|
||
|
Accrued costs related to restructuring
|
795
|
|
|
60
|
|
||
|
Deferred revenue
|
458
|
|
|
—
|
|
||
|
Liability for warranty returns
|
34
|
|
|
28
|
|
||
|
Other
|
3,831
|
|
|
709
|
|
||
|
Accrued liabilities and current portion of long-term liabilities
|
$
|
16,199
|
|
|
$
|
7,860
|
|
|
|
Nine Months Ended
|
||||||
|
|
September 30,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Liability for warranty returns:
|
|
|
|
||||
|
Balance at beginning of period
|
$
|
28
|
|
|
$
|
49
|
|
|
Provision (benefit)
|
15
|
|
|
(4
|
)
|
||
|
Charge-offs
|
(9
|
)
|
|
(20
|
)
|
||
|
Balance at end of period
|
$
|
34
|
|
|
$
|
25
|
|
|
10% convertible notes, principal amount
|
$
|
5,149
|
|
|
Unamortized debt discount
|
(1,234
|
)
|
|
|
Conversion feature, at fair value
|
1,846
|
|
|
|
|
$
|
5,761
|
|
|
•
|
Currency
- The convertible debt is denominated in Canadian dollars, with principal and interest payments made in Canadian dollars. As a result, we record foreign currency transaction gains or losses in our statement of operations related to the convertible debt.
|
|
•
|
Interest
- Stated rate of
10%
per year, payable semi-annually. If the
five
day volume weighted average market price of our common stock exceeds the U.S. dollar equivalent of CAD
$16.54
for
15
consecutive trading days, the interest rate will reset to a fixed rate of
1.0%
. The
five
day volume weighted average market price for our common stock did not exceed such threshold during the three months ended September 30, 2017.
|
|
•
|
Maturity
-
$2,484
of the principal amount of convertible notes is due September 2019 and
$2,665
is due January 2020.
|
|
•
|
Conversion Option
- Convertible at any time at the option of the holders into our common stock at a conversion price of CAD
$7.24
per share for the convertible notes due September 2019 (of which the principal outstanding amount in Canadian dollars is CAD
$3,040
) and CAD
$7.13
per share for the convertible notes due January 2020 (of which the principle outstanding amount in Canadian dollars is CAD
$3,324
), or
892,751
shares.
|
|
•
|
Redemption
- Through December 31, 2017, we may redeem the convertible debt for
110%
of the principal amount plus accrued and unpaid interest. Thereafter, we may redeem the convertible debt for
100%
of the principal amount plus accrued and unpaid interest.
|
|
•
|
Default
- There are certain events that require us to redeem the outstanding convertible debt for
100%
of the principal plus accrued and unpaid interest. Such events include, but are not limited to, the failure to pay principal or interest in accordance with the terms of the agreement, the sale of intellectual property without the consent of the holders, and a change in control.
|
|
Level 1:
|
Valuations based on quoted prices in active markets for identical assets and liabilities.
|
|
Level 2:
|
Valuations based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
|
|
Level 3:
|
Valuations based on unobservable inputs in which there is little or no market data available, which require the reporting entity to develop its own assumptions.
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
As of September 30, 2017:
|
|
|
|
|
|
|
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Money market funds
|
$
|
23,626
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
23,626
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Convertible debt - including conversion feature
|
$
|
—
|
|
|
$
|
5,450
|
|
|
$
|
—
|
|
|
$
|
5,450
|
|
|
Conversion feature - convertible debt
|
—
|
|
|
1,846
|
|
|
—
|
|
|
1,846
|
|
||||
|
As of December 31, 2016:
|
|
|
|
|
|
|
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Money market funds
|
$
|
17,960
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
17,960
|
|
|
|
Nine Months Ended
|
||||||
|
|
September 30,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Cost of revenue — restructuring:
|
|
|
|
||||
|
Tooling and inventory write offs
|
—
|
|
|
1,679
|
|
||
|
Employee severance and benefits
|
—
|
|
|
98
|
|
||
|
|
—
|
|
|
1,777
|
|
||
|
|
|
|
|
||||
|
Operating expenses — restructuring:
|
|
|
|
||||
|
Employee severance and benefits
|
$
|
1,481
|
|
|
$
|
2,513
|
|
|
Licensed technology and other assets write offs
|
—
|
|
|
65
|
|
||
|
Other
|
—
|
|
|
30
|
|
||
|
|
1,481
|
|
|
2,608
|
|
||
|
Total restructuring expense
|
$
|
1,481
|
|
|
$
|
4,385
|
|
|
|
Balance as of December 31, 2016
|
|
Expensed
|
|
Payments
|
|
Balance as of September 30, 2017
|
||||||||
|
Employee severance and benefits
|
$
|
60
|
|
|
$
|
1,481
|
|
|
$
|
(746
|
)
|
|
$
|
795
|
|
|
Accrued costs related to restructuring
|
$
|
60
|
|
|
$
|
1,481
|
|
|
$
|
(746
|
)
|
|
$
|
795
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Interest expense
1
|
$
|
(385
|
)
|
|
$
|
(107
|
)
|
|
$
|
(631
|
)
|
|
$
|
(337
|
)
|
|
Fair value adjustment on convertible debt conversion option
|
(122
|
)
|
|
—
|
|
|
(122
|
)
|
|
—
|
|
||||
|
Discount accretion on convertible debt fair value
|
(72
|
)
|
|
—
|
|
|
(72
|
)
|
|
—
|
|
||||
|
Interest income
|
51
|
|
|
8
|
|
|
97
|
|
|
32
|
|
||||
|
Total interest expense and other, net
|
$
|
(528
|
)
|
|
$
|
(99
|
)
|
|
$
|
(728
|
)
|
|
$
|
(305
|
)
|
|
1
|
Increase in the 2017 periods compared to the 2016 periods due to contractual interest on convertible debt, as well as imputed interest on short and long-term liabilities acquired as a part of the Acquisition.
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Net loss
|
$
|
(4,706
|
)
|
|
$
|
(1,242
|
)
|
|
$
|
(621
|
)
|
|
$
|
(11,444
|
)
|
|
Weighted average shares outstanding - basic and diluted
|
32,552
|
|
|
28,313
|
|
|
30,545
|
|
|
28,139
|
|
||||
|
Net loss per share - basic and diluted
|
$
|
(0.14
|
)
|
|
$
|
(0.04
|
)
|
|
$
|
(0.02
|
)
|
|
$
|
(0.41
|
)
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
|
September 30,
|
|
September 30,
|
||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||
|
Employee equity incentive plans
|
4,035
|
|
|
4,952
|
|
|
3,853
|
|
|
4,643
|
|
|
Convertible debt
|
625
|
|
|
—
|
|
|
211
|
|
|
—
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Japan
|
$
|
17,303
|
|
|
$
|
11,255
|
|
|
$
|
50,664
|
|
|
$
|
31,207
|
|
|
China
|
631
|
|
|
394
|
|
|
1,227
|
|
|
891
|
|
||||
|
United States
|
454
|
|
|
20
|
|
|
575
|
|
|
74
|
|
||||
|
Taiwan
|
218
|
|
|
1,268
|
|
|
6,315
|
|
|
3,537
|
|
||||
|
Europe
|
118
|
|
|
175
|
|
|
2,059
|
|
|
475
|
|
||||
|
Korea
|
34
|
|
|
273
|
|
|
821
|
|
|
688
|
|
||||
|
Other
|
—
|
|
|
271
|
|
|
528
|
|
|
531
|
|
||||
|
|
$
|
18,758
|
|
|
$
|
13,656
|
|
|
$
|
62,189
|
|
|
$
|
37,403
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
|
September 30,
|
|
September 30,
|
||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||
|
Distributors:
|
|
|
|
|
|
|
|
||||
|
All distributors
|
40
|
%
|
|
35
|
%
|
|
46
|
%
|
|
42
|
%
|
|
Distributor A
|
25
|
%
|
|
17
|
%
|
|
27
|
%
|
|
24
|
%
|
|
End customers:
1
|
|
|
|
|
|
|
|
||||
|
Top five end customers
|
88
|
%
|
|
83
|
%
|
|
79
|
%
|
|
82
|
%
|
|
End customer A
|
60
|
%
|
|
62
|
%
|
|
48
|
%
|
|
54
|
%
|
|
End customer B
|
8
|
%
|
|
2
|
%
|
|
10
|
%
|
|
7
|
%
|
|
1
|
End customers include customers who purchase directly from us, as well as customers who purchase our products indirectly through distributors.
|
|
|
September 30,
2017 |
|
December 31,
2016 |
||
|
Account X
|
70
|
%
|
|
54
|
%
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||||||||
|
|
2017
|
|
2016
|
|
% Change
|
|
2017
|
|
2016
|
|
% Change
|
||||||||||
|
Revenue, net
|
$
|
18,758
|
|
|
$
|
13,656
|
|
|
37
|
%
|
|
$
|
62,189
|
|
|
$
|
37,403
|
|
|
66
|
%
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||||||||||||||
|
|
2017
|
|
% of
revenue
|
|
2016
|
|
% of
revenue
|
|
2017
|
|
% of
revenue
|
|
2016
|
|
% of
revenue
|
||||||||||||
|
Direct product costs and related overhead
1
|
$
|
8,479
|
|
|
45
|
%
|
|
$
|
7,001
|
|
|
51
|
%
|
|
$
|
28,122
|
|
|
45
|
%
|
|
$
|
18,889
|
|
|
51
|
%
|
|
Inventory step-up and backlog amortization
|
1,016
|
|
|
5
|
|
|
—
|
|
|
0
|
|
|
1,016
|
|
|
2
|
|
|
—
|
|
|
0
|
|
||||
|
Amortization of acquired developed technology
|
199
|
|
|
1
|
|
|
—
|
|
|
0
|
|
|
199
|
|
|
0
|
|
|
—
|
|
|
0
|
|
||||
|
Stock-based compensation
|
57
|
|
|
0
|
|
|
49
|
|
|
0
|
|
|
179
|
|
|
0
|
|
|
139
|
|
|
0
|
|
||||
|
Inventory charges
2
|
(4
|
)
|
|
0
|
|
|
22
|
|
|
0
|
|
|
69
|
|
|
0
|
|
|
34
|
|
|
0
|
|
||||
|
Restructuring
|
—
|
|
|
0
|
|
|
27
|
|
|
0
|
|
|
—
|
|
|
0
|
|
|
1,777
|
|
|
5
|
|
||||
|
Total cost of revenue
|
$
|
9,747
|
|
|
52
|
%
|
|
$
|
7,099
|
|
|
52
|
%
|
|
$
|
29,585
|
|
|
48
|
%
|
|
$
|
20,839
|
|
|
56
|
%
|
|
Gross profit
|
$
|
9,011
|
|
|
48
|
%
|
|
$
|
6,557
|
|
|
48
|
%
|
|
$
|
32,604
|
|
|
52
|
%
|
|
$
|
16,564
|
|
|
44
|
%
|
|
1
|
Includes purchased materials, assembly, test, labor, employee benefits and royalties.
|
|
2
|
Includes charges to reduce inventory to lower of cost or market and a benefit for sales of previously written down inventory.
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||||||||
|
|
2017
|
|
2016
|
|
% Change
|
|
2017
|
|
2016
|
|
% Change
|
||||||||||
|
Research and development
|
$
|
5,325
|
|
|
$
|
4,442
|
|
|
20
|
%
|
|
$
|
14,732
|
|
|
$
|
14,621
|
|
|
1
|
%
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||||||||
|
|
2017
|
|
2016
|
|
% Change
|
|
2017
|
|
2016
|
|
% Change
|
||||||||||
|
Selling, general and administrative
|
$
|
6,583
|
|
|
$
|
3,072
|
|
|
114
|
%
|
|
$
|
15,382
|
|
|
$
|
10,117
|
|
|
52
|
%
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Employee severance and benefits
|
$
|
1,481
|
|
|
$
|
30
|
|
|
$
|
1,481
|
|
|
$
|
2,611
|
|
|
Write off of assets
|
—
|
|
|
—
|
|
|
—
|
|
|
1,744
|
|
||||
|
Other
|
—
|
|
|
—
|
|
|
—
|
|
|
30
|
|
||||
|
Total restructuring expense
|
$
|
1,481
|
|
|
$
|
30
|
|
|
$
|
1,481
|
|
|
$
|
4,385
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Included in cost of revenue
|
$
|
—
|
|
|
$
|
27
|
|
|
$
|
—
|
|
|
$
|
1,777
|
|
|
Included in operating expenses
|
1,481
|
|
|
3
|
|
|
1,481
|
|
|
2,608
|
|
||||
|
|
Payments Due By Period
|
||||||||||||||||||
|
Contractual Obligation
|
Total
|
|
Less than
1 year
|
|
1-3 years
|
|
3-5 years
|
|
More than 5 years
|
||||||||||
|
Estimated purchase commitments to contract manufacturers
|
$
|
7,285
|
|
|
$
|
7,285
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Convertible debt
|
5,149
|
|
|
—
|
|
|
5,149
|
|
|
—
|
|
|
—
|
|
|||||
|
Operating leases
|
5,534
|
|
|
2,502
|
|
|
2,623
|
|
|
409
|
|
|
—
|
|
|||||
|
Payments on accrued balances related to asset financings
|
3,332
|
|
|
1,948
|
|
|
1,384
|
|
|
—
|
|
|
—
|
|
|||||
|
Interest on convertible debt
|
1,163
|
|
|
515
|
|
|
648
|
|
|
—
|
|
|
—
|
|
|||||
|
Other purchase obligations and commitments
|
1,729
|
|
|
206
|
|
|
541
|
|
|
561
|
|
|
421
|
|
|||||
|
Total
1
|
$
|
24,192
|
|
|
$
|
12,456
|
|
|
$
|
10,345
|
|
|
$
|
970
|
|
|
$
|
421
|
|
|
1
|
We are unable to reliably estimate the timing of future payments related to uncertain tax positions and repatriation of foreign earnings; therefore, $2.2 million of income taxes payable has been excluded from the table above.
|
|
Item 4.
|
Controls and Procedures.
|
|
Item 1A.
|
Risk Factors.
|
|
•
|
difficulties in managing international distributors and manufacturers due to varying time zones, languages and business customs;
|
|
•
|
compliance with U.S. laws affecting operations outside of the U.S., such as the Foreign Corrupt Practices Act;
|
|
•
|
reduced or limited protection of our IP, particularly in software, which is more prone to design piracy;
|
|
•
|
difficulties in collecting outstanding accounts receivable balances;
|
|
•
|
changes in tax rates, tax laws and the interpretation of those laws;
|
|
•
|
difficulties regarding timing and availability of export and import licenses;
|
|
•
|
ensuring that we obtain complete and accurate information from our Asian operations to make proper disclosures in the United States;
|
|
•
|
political and economic instability;
|
|
•
|
difficulties in maintaining sales representatives outside of the U.S. that are knowledgeable about our industry and products;
|
|
•
|
changes in the regulatory environment in the PRC, Japan, Taiwan and Korea that may significantly impact purchases of our products by our customers or our customers’ sales of their own products;
|
|
•
|
outbreaks of health epidemics in the PRC or other parts of Asia;
|
|
•
|
imposition of new tariffs, quotas, trade barriers and similar trade restrictions on our sales;
|
|
•
|
varying employment and labor laws; and
|
|
•
|
greater vulnerability to infrastructure and labor disruptions than in established markets.
|
|
•
|
reduced end user demand due to the economic impact of any natural disaster;
|
|
•
|
a disruption to the global supply chain for products manufactured in areas affected by natural disasters that are included in products purchased either by us or by our customers;
|
|
•
|
an increase in the cost of products that we purchase due to reduced supply; and
|
|
•
|
other unforeseen impacts as a result of the uncertainty resulting from a natural disaster.
|
|
•
|
difficulties in hiring and retaining necessary technical personnel;
|
|
•
|
difficulties in reallocating engineering resources and overcoming resource limitations;
|
|
•
|
difficulties with contract manufacturers;
|
|
•
|
changes to product specifications and customer requirements;
|
|
•
|
changes to market or competitive product requirements; and
|
|
•
|
unanticipated engineering complexities.
|
|
•
|
stop selling products using technology that contains the allegedly infringing IP;
|
|
•
|
attempt to obtain a license to the relevant IP, which may not be available on terms that are acceptable to us or at all;
|
|
•
|
attempt to redesign those products that contain the allegedly infringing IP; or
|
|
•
|
pay damages for past infringement claims that are determined to be valid or which are arrived at in settlement of such litigation or threatened litigation.
|
|
•
|
actual or anticipated fluctuations in our operating results;
|
|
•
|
changes in or failure to meet expectations as to our future financial performance;
|
|
•
|
changes in or failure to meet financial estimates of securities analysts;
|
|
•
|
announcements by us or our competitors of technological innovations, design wins, contracts, standards, acquisitions or divestitures;
|
|
•
|
Failure to realize the anticipated benefits of the acquisition of ViXS, and unanticipated costs related thereto;
|
|
•
|
the operating and stock price performance of other comparable companies;
|
|
•
|
issuances or proposed issuances of equity, debt or other securities by us, or sales of securities by our security holders; and
|
|
•
|
changes in market valuations of other technology companies.
|
|
•
|
if the number of directors is fixed by the board at eight or more, our board of directors is divided into three classes serving staggered terms, which would make it more difficult for a group of shareholders to quickly replace a majority of directors;
|
|
•
|
our board of directors is authorized, without prior shareholder approval, to create and issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to acquire us or to effect a change of control, commonly referred to as "blank check" preferred stock;
|
|
•
|
members of our board of directors can be removed only for cause and at a meeting of shareholders called expressly for that purpose, by the vote of 75 percent of the votes then entitled to be cast for the election of directors;
|
|
•
|
our board of directors may alter our bylaws without obtaining shareholder approval; and shareholders are required to provide advance notice for nominations for election to the board of directors or for proposing matters to be acted upon at a shareholder meeting;
|
|
•
|
Oregon law permits our board to consider other factors beyond stockholder value in evaluating any acquisition offer (so-called "expanded constituency" provisions); and
|
|
•
|
a supermajority (67%) vote of shareholders is required to approve certain fundamental transactions.
|
|
Item 6.
|
Exhibits.
|
|
2.1
|
|
|
|
|
|
|
|
2.2
|
|
|
|
|
|
|
|
3.1
|
|
|
|
|
|
|
|
3.2
|
|
|
|
|
|
|
|
3.3
|
|
|
|
|
|
|
|
4.1
|
|
|
|
|
|
|
|
4.2
|
|
|
|
|
|
|
|
10.1
|
|
|
|
|
|
|
|
31.1
|
|
|
|
|
|
|
|
31.2
|
|
|
|
|
|
|
|
32.1*
|
|
|
|
|
|
|
|
32.2*
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Label Linkbase Document
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
*
|
Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be "filed" for under the Securities Act of 1933, as amended (the “Securities Act”) or the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language contained in such filing, except to the extent specifically stated in such filing.
|
|
|
|
PIXELWORKS, INC.
|
|
|
|
|
|
Dated:
|
November 14, 2017
|
/s/ Steven L. Moore
|
|
|
|
Steven L. Moore
Vice President, Chief Financial Officer,
Secretary and Treasurer
(Duly Authorized Officer and Principal Accounting and Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|